CD4 and neoplasm: Using flow cytometry–based immunoprofiling, we examined changes in viable T lymphocytes (CD3+), helper T cells (CD3+/CD4+), and cytotoxic T cells (CD3+/CD8+) in the baseline PBMCs versus in the immune cells isolated from the cocultures (tumor-stimulated immune cells, “ts-immune”).